摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 6-iodo-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxylate | 1239604-50-2

中文名称
——
中文别名
——
英文名称
ethyl 6-iodo-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxylate
英文别名
Ethyl 6-iodo-4-oxo-1-pentylquinoline-3-carboxylate
ethyl 6-iodo-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxylate化学式
CAS
1239604-50-2
化学式
C17H20INO3
mdl
——
分子量
413.255
InChiKey
JSLIIGOHGVTBKI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    22
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 6-iodo-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxylate 、 sodium hydroxide 作用下, 反应 3.0h, 以65%的产率得到6-iodo-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxylic acid
    参考文献:
    名称:
    Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure−Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands
    摘要:
    A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting K(i) > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with K(i) values ranging from 73.2 to 0.7 nM and selectivity [SI = K(i)(CB1)/K(i)(CB2)] varying from > 14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo test. However, two different functional assays carried out in vitro on 2e and 2g indicated for both compounds an overall inverse agonist activity at CB2 receptors.
    DOI:
    10.1021/jm100123x
  • 作为产物:
    描述:
    1-碘戊烷6-碘-4-氧代-1,4-二氢喹啉-3-羧酸乙酯potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 以74%的产率得到ethyl 6-iodo-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxylate
    参考文献:
    名称:
    Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure−Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands
    摘要:
    A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting K(i) > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with K(i) values ranging from 73.2 to 0.7 nM and selectivity [SI = K(i)(CB1)/K(i)(CB2)] varying from > 14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo test. However, two different functional assays carried out in vitro on 2e and 2g indicated for both compounds an overall inverse agonist activity at CB2 receptors.
    DOI:
    10.1021/jm100123x
点击查看最新优质反应信息

文献信息

  • [EN] ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS<br/>[FR] MACROLIDES A LIAISON ESTER UTILES POUR LE TRAITEMENT D'INFECTION MICROBIENNES
    申请人:PLIVA ISTRAZIVACKI INST D O O
    公开号:WO2005108412A1
    公开(公告)日:2005-11-17
    The present invention relates to 14- or 15-membered macrolides substituted at the 4” position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infoections in a human or animal body.
    本发明涉及在式(I)的4”位置被取代的14-或15-环大环内酯及其药学上可接受的衍生物,以及它们的制备方法和在人体或动物体内治疗或预防全身或局部微生物感染中的用途。
  • ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS
    申请人:GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
    公开号:EP1756135A1
    公开(公告)日:2007-02-28
查看更多